InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2024-10-02 00:00:00 ET · period of report 2024-10-01 · accession 0001576280-24-000238 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-10-02 2024-10-01 GH Freeman Chris Chief Commercial Off F - Tax $22.12 -3,620 31.5K -10% -$80.1K
DM 2024-10-02 2024-10-01 GH Freeman Chris Chief Commercial Off M - OptEx $0.00 +8,498 28.5K +42% $0
DM 2024-10-02 2024-10-01 GH Freeman Chris Chief Commercial Off M - OptEx $0.00 -8,498 15.4K -36% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-01 F D 3,620 $22.12 31,452 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2 Common Common Stock 2024-10-01 M A 6,569 $0.00 35,072 D — —
3 Common Common Stock 2024-10-01 M A 1,929 $0.00 28,503 D — —
4 Derivative Restricted Stock Units 2024-10-01 M D 6,569 $0.00 13,338 D $0.00 · — to — 6,569 Common Stock (F4) This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units.
5 Derivative Restricted Stock Units 2024-10-01 M D 1,929 $0.00 15,427 D $0.00 · — to — 1,929 Common Stock (F2) This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. (F3) Not applicable for Restricted Stock Units.